-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Neurocrine Biosciences Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to 2023.
- Neurocrine Biosciences Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 104M shares, a 3.69% increase year-over-year.
- Neurocrine Biosciences Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 101M shares, a 2.12% increase from 2022.
- Neurocrine Biosciences Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 98.9M shares, a 1.02% increase from 2021.
- Neurocrine Biosciences Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 97.9M shares, a 0.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)